Interferon-gamma enhances cytotoxic T lymphocyte recognition of endogenous peptide in keratinocytes without lowering the requirement for surface peptide

被引:24
作者
Leggatt, GR [1 ]
Dunn, LA [1 ]
De Kluyver, RL [1 ]
Stewart, T [1 ]
Frazer, IH [1 ]
机构
[1] Univ Queensland, Princess Alexandra Hosp, Ctr Immunol & Canc Res, Brisbane, Qld 4102, Australia
关键词
antigen presentation/processing; CTL; cytotoxicity; keratinocytes; skin;
D O I
10.1046/j.1440-1711.2002.01105.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Keratinocytes expressing the human papillomavirus (HPV) type 16 E7 protein, as a transgene driven by the K14 promoter, form a murine model of HPV-mediated epithelial cancers in humans. Our previous studies have shown that K14E7 transgenic skin grafts onto syngeneic mice are not susceptible to immune destruction despite the demonstrated presence of a strong, systemic CTL response directed against the E7 protein. Consistent with this finding, we now show that cultured, E7 transgenic keratinocytes (KC) express comparable endogenous levels of E7 protein to a range of CTL-sensitive E7-expressing cell lines but are not susceptible to CTL-mediated lysis in vitro . E7 transgenic and non-transgenic KC are susceptible to conventional mechanisms of CTL-mediated lysis, including perforin and Fas/FasL interaction when an excess of exogenous peptide is provided. The concentration of exogenous peptide required to render a cell susceptible to lysis was similar between KC and other conventional CTL targets (e.g. EL-4), despite large differences in H-2D(b) expression at the cell surface. Furthermore, exposure of KC to IFN-gamma increased H-2D(b) expression, but did not substantially alter the exogenous peptide concentration required to sensitize cells for half maximal lysis. In contrast, the lytic sensitivity of transgenic KC expressing endogenous E7 is modestly improved by exposure to IFN-gamma. Thus, failure of CTL to eliminate KC expressing endogenous E7, and by inference squamous tumours expressing E7, may reflect the need for a sustained, local inflammatory environment during the immune effector phase.
引用
收藏
页码:415 / 424
页数:10
相关论文
共 41 条
[1]   The human papillomavirus E7 protein is able to inhibit the antiviral and anti-growth functions of interferon-α [J].
Barnard, P ;
Payne, E ;
McMillan, NAJ .
VIROLOGY, 2000, 277 (02) :411-419
[2]   Cellular responses to interferon-gamma [J].
Boehm, U ;
Klamp, T ;
Groot, M ;
Howard, JC .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :749-795
[3]   E7-specific cytotoxic T cell tolerance in HPV-transgenic mice [J].
Borchers, A ;
Braspenning, J ;
Meijer, J ;
Osen, W ;
Gissmann, L ;
Jochmus, I .
ARCHIVES OF VIROLOGY, 1999, 144 (08) :1539-1556
[4]   CULTURED MOUSE KERATINOCYTE ALLOGRAFTS PRIME FOR ACCELERATED 2ND SET REJECTION AND ENHANCED CYTOTOXIC LYMPHOCYTE-RESPONSE [J].
CAIRNS, BA ;
DESERRES, S ;
MATSUI, M ;
FRELINGER, JA ;
MEYER, AA .
TRANSPLANTATION, 1994, 58 (01) :67-72
[5]   Immunological ignorance of silent antigens as an explanation of tumor evasion [J].
Chen, LP .
IMMUNOLOGY TODAY, 1998, 19 (01) :27-30
[6]   A NEW SENSITIVE ASSAY FOR MEASUREMENT OF CELL-MEDIATED CYTOTOXICITY TO INTACT LAYERS OF CULTURED HUMAN KERATINOCYTES [J].
DEBUEGER, MM ;
VANELS, CACM ;
KEMPENAAR, J ;
PONEC, M ;
GOULMY, E .
JOURNAL OF IMMUNOLOGICAL METHODS, 1990, 127 (01) :117-122
[7]   Human papillomavirus type 16 E7 oncoprotein expressed in peripheral epithelium tolerizes E7-directed cytotoxic T-lymphocyte precursors restricted through human (and mouse) major histocompatibility complex class I alleles [J].
Doan, T ;
Herd, K ;
Street, M ;
Bryson, G ;
Fernando, G ;
Lambert, P ;
Tindle, R .
JOURNAL OF VIROLOGY, 1999, 73 (07) :6166-6170
[8]   THE HUMAN PAPILLOMA VIRUS-16 E7-ONCOPROTEIN IS ABLE TO BIND TO THE RETINOBLASTOMA GENE-PRODUCT [J].
DYSON, N ;
HOWLEY, PM ;
MUNGER, K ;
HARLOW, E .
SCIENCE, 1989, 243 (4893) :934-937
[9]   VACCINATION WITH CYTOTOXIC T-LYMPHOCYTE EPITOPE-CONTAINING PEPTIDE PROTECTS AGAINST A TUMOR-INDUCED BY HUMAN PAPILLOMAVIRUS TYPE-16-TRANSFORMED CELLS [J].
FELTKAMP, MCW ;
SMITS, HL ;
VIERBOOM, MPM ;
MINNAAR, RP ;
DEJONGH, BM ;
DRIJFHOUT, JW ;
TERSCHEGGET, J ;
MELIEF, CJM ;
KAST, WM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (09) :2242-2249
[10]   T-HELPER EPITOPES OF THE E7 TRANSFORMING PROTEIN OF CERVICAL-CANCER ASSOCIATED HUMAN PAPILLOMAVIRUS TYPE-18 (HPV18) [J].
FERNANDO, GJP ;
TINDLE, RW ;
FRAZER, RW .
VIRUS RESEARCH, 1995, 36 (01) :1-13